ELMSFORD, NY (March 1, 2007) - Reveo recently attended the 8th Annual Advances in Genome Biology and Technology (AGBT) Conference in Marco Island, Florida (February 7-10, 2007) and presented a new figure of merit to objectively compare all sequencing instruments that is independent of the underlying technology. This figure of merit which incorporates the total cost to sequence an entire genome, total time to sequence an entire genome, cumulative errors generated during sequencing and comprehensiveness of the sequencing coverage is called the CTEC Index. This new benchmark was developed to objectively compare the advantages and limitations of each sequencing instrument guiding scientists, engineers, investors and entrepreneurs to pursue the most promising paths towards the realization of personalized medicine and fundamental discoveries in developmental biology.
Additionally, Reveo presented a significant milestone accomplishment with their Omni Molecular Recognizer Application (OmniMoRA) sequencing instrument – a non-destructive, direct read approach to DNA sequencing using all solid-state based components. Reveo has now developed proprietary fabrication techniques to create atomically sharp nano-knife edge blades for use as detectors in the OmniMoRA. Reveo has also developed proprietary concepts that enable them to tailor the shape and slope of the nano-knife edge blades and transfer the nano-knife edge blades from one solid surface to another. The impact of these discoveries (inventions) is far-reaching – well beyond the scope of the OmniMoRA instrument. These nano-knife edge blades can now serve as nano-cutting and nano-detection tools to enable pioneering research and innovations in other disciplines on the nano and sub-nanoscale.
A PDF file with more detailed information on the CTEC Index is located here.